Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 14, 2009; 15(26): 3261-3268
Published online Jul 14, 2009. doi: 10.3748/wjg.15.3261
Published online Jul 14, 2009. doi: 10.3748/wjg.15.3261
Table 1 The clinical characteristics of the study subjects
Probiotic | Placebo | P-value | |
N | 24 | 23 | |
Drop-outs | 2 | 1 | P > 0.99 |
Age (yr) | 9.0 (4.2-11.9) | 8.9 (6.1-12.9) | P = 0.845 |
Gender (M/F) | 11 (13) | 8 (15) | P = 0.24 |
Length (cm) | 135.2 (107.3-156.5) | 133.6 (113.8-152.5) | P = 0.50 |
Weight (kg) | 31.0 (11.9-47.4) | 32.4 (20.2-45.3) | P = 0.80 |
Table 2 Number of subjects with nasal eosinophilia n (%)
Month | Placebo | Probiotic |
March | 14 (63.6) | 17 (70.8) |
April/May | 19 (95.0) | 12 (57.1)1 |
June | 12 (60.0) | 12 (60.0) |
Table 3 Serum immune markers; before, during and after the birch pollen season, median
March | April/May | June | ||||
Placebo | Probiotic | Placebo | Probiotic | Placebo | Probiotic | |
Specific IgE birch pollen (kU/L) | 26.0 (18.0-45.8) | 25.5 (15.5-54.0) | - | - | 150.00 (36.0-150.0)1 | 150.00 (150.0-150.0)1 |
Blood eosinophils (109/L) | 0.30 (0.24-0.44) | 0.18 (0.12-0.34) | - | - | 0.40 (0.25-0.72)1 | 0.42 (0.28-069)1 |
IL-4 (pg/mL) | 2.20 (1.5-2.8) | 1.70 (0.0-2.2) | 1.70 (0.8-2.2) | 1.7 (1.3-2.1) | - | - |
IL-5 (pg/mL) | 19.6 (0.0-69.7) | 9.10 (0.0-24.2) | 14.70 (0.0-28.3) | 18.4 (0.0-60.2) | - | - |
IL-6 (pg/mL) | 16.6 (5.7-38.3) | 4.70 (3.0-11.4)3 | 4.20 (2.3-7.3)1 | 3.0 (2.0-3.9)1 | - | - |
IL-10 (pg/mL) | 1.60 (1.4-1.9) | 1.50 (0.0-2.1) | 1.40 (0.0-1.8)2 | 0.0 (0.0-1.5) | - | - |
TNF-α (pg/mL) | 7.70 (3.9-13.5) | 3.50 (2.5-5.2)3 | 2.90 (2.3-4.8)1 | 2.5 (2.1-3.2)1 | - | - |
TGF-β2 (pg/mL) | 242 (0.0-342) | 247 (0.0-369) | 213.6 (0.0-314.3) | 267.9 (0.0-445.9) | - | - |
CD-14 (&mgr;g/mL) | 1.20 (1.1-1.3) | 1.20 (1.1-1.3) | - | - | 1.20 (1.1-1.3) | 1.10 (1.1-1.3) |
Table 4 Fecal immune markers; before, during and after the birch pollen season
Visit 1 (March) | Visit 2 (April/May) | Visit 3 (June) | ||||
Placebo | Probiotic | Placebo | Probiotic | Placebo | Probiotic | |
Fecal IgA (&mgr;g/g) | 157.0 (105.0-278.8) | 157.0 (114.0-371.0) | 233.0 (136.0-288.8)1 | 155.0 (44.5-336.5)1 | 203.0 (99.0-388.0)1 | 135.0 (63.4-325.3)1 |
Fecal calprotectin (&mgr;g/g) | 21.6 (9.5-58.6) | 14.3 (10.7-30.1) | 21.1 (12.6-46.7) | 16.2 (13.1-31.8) | 22.1 (10.9-53.2) | 15.5 (12.0-31.5) |
Table 5 Alteration of the fecal microbiota composition during the birch pollen season
March | April/May | June | ||||
Placebo | Probiotic | Placebo | Probiotic | Placebo | Probiotic | |
Eubacterium4 | 2.7 × 109 (0.3 × 109) | 2.5 × 109 (0.4 × 109) | 1.8 × 109 (1.0 × 109) | 1.6 × 109 (0.2 × 109)2 | 2.00 × 109 (0.2 × 109) | 1.9 × 109 (0.3 × 109) |
Bifidobacterium4 | 5.0 × 108 (5.0 × 108) | 3.5 × 108 (3.3 × 108) | 2.1 × 108 (0.4 × 108)2 | 1.6 × 108 (0.3 × 108)1 | 2.50 × 108 (0.4 × 108) | 2.0 × 108 (0.2 × 108) |
Bacteroides4 | 4.9 × 108 (3.5 × 108) | 5.4 × 108 (3.2 × 108) | 2.3 × 108 (0.4 × 108)2 | 1.7 × 108 (0.3 × 108)1 | 1.30 × 108 (0.2 × 108) | 1.5 × 108 (0.4 × 108) |
Clostridium4 | 1.4 × 108 (1.0 × 108) | 1.5 × 108 (0.3 × 108) | 0.7 × 108 (0.2 × 108)2 | 0.8 × 108 (0.2 × 108)1 | 1.30 × 108 (0.3 × 108)2 | 1.6 × 108 (0.2 × 108)1 |
Akkermansia4 | 1.3 × 108 (0.2 × 108) | 1.3 × 108 (0.2 × 108) | 1.2 × 108 (0.2 × 108) | 1.1 × 108 (0.1 × 108) | 0.90 × 108 (0.2 × 108) | 1.1 × 108 (0.2 × 108) |
B. lactis5 | 2.6 × 107 (1.7 × 107) | 1.5 × 107 (1.3 × 107) | 0.1 × 107 (0.1 × 107) | 11.2 × 107 (4.2 × 107)13 | 0.01 × 107 (0.05 × 107) | 2.6 × 107 (1.0 × 107)13 |
L. acidophilus NCFM5 | 1.0 × 106 (0.8 × 106) | 0.7 × 106 (0.5 × 106) | 0.2 × 106 (0.1 × 106)1 | 3.5 × 106 (1.3 × 106)3 | 0.02 × 106 (0.1 × 106) | 4.2 × 106 (2.4 × 106)3 |
Table 6 Concentrations of fecal organic acids (mmol/kg)
March | April/May | June | ||||
Placebo | Probiotic | Placebo | Probiotic | Placebo | Probiotic | |
Acetic acid | 64.6 (6.0) | 74.50 (7.2) | 59.20 (5.6) | 65.50 (5.8) | 66.90 (5.1) | 58.20 (4.5) |
Propionic acid | 15.5 (1.3) | 17.10 (1.6) | 15.20 (1.2) | 16.10 (2.1) | 16.20 (1.9) | 14.60 (1.5) |
Isobutyric acid | 2.30 (0.3) | 2.20 (0.2) | 2.00 (0.2) | 1.90 (0.1) | 1.80 (0.2) | 1.90 (0.2) |
Butyric acid | 11.9 (2.0) | 13.40 (2.5) | 12.50 (1.2) | 11.70 (1.7) | 14.00 (1.8) | 11.50 (1.7) |
2-methylbutyric acid | 1.60 (0.2) | 1.30 (0.2) | 1.60 (0.2) | 1.20 (0.1) | 1.10 (0.1)1 | 1.20 (0.2) |
Isovaleric acid | 1.80 (0.2) | 1.70 (0.1) | 1.60 (0.2) | 1.50 (0.1) | 1.50 (0.2) | 1.50 (0.2) |
Lactic acid | 0.14 (0.14) | 0.83 (0.56) | 0.00 (0.00) | 0.14 (0.14) | 0.36 (0.25) | 0.50 (0.38) |
Valeric acid | 2.70 (0.3) | 2.60 (0.3) | 2.70 (0.2) | 2.50 (0.2) | 2.60 (0.3) | 2.50 (0.3) |
Capronic acid | 0.06 (0.06) | 0.31 (0.20) | 0.17 (0.12) | 0.27 (0.16) | 0.03 (0.03) | 0.22 (0.09) |
- Citation: Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009; 15(26): 3261-3268
- URL: https://www.wjgnet.com/1007-9327/full/v15/i26/3261.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3261